Assessing Immune Biomarkers in Tumor Microenvironments to Provide Predictive Responses

Time: 1:30 pm
day: Conference Day One


  • Understanding the potential of these biomarkers by observing their behavior in the context of vaccine checkpoints and combinations to identify which biomarkers are most closely associated with positive outcomes
  • Considering the characteristics of the tumor to understand what certain cancer subtypes may be more amenable to vaccine therapy than others
  • Exploring the factors that influence these biomarkers and the immune response they elicit, to develop more effective vaccines